(Unaudited data) In thousands of euros 2021 2020 Variation at current
exchange rates Variation at constant exchange rates France 51,518 72,820 -29.3% -29.3% Europe
BOIRON: 2020 results
The Board of Directors of BOIRON, at its meeting on March 10, 2021 chaired by Thierry Boiron, made up the statutory and consolidated financial statements of the financial year ended on December 31, 2020. It was decided to call a Mixed Shareholders Meeting on May 27, 2021 at the company s headquarters in Messimy.
Audit of the statutory and consolidated financial statements have been performed and the audit reports concerning their certification are currently in the process of being issued.
BOIRON GROUP RESULTS
+12.7%
(1) The main information on the variation of the yearly sales were the subject of a financial statement on January 21, 2021 (https://www.boironfinance.fr/en/releases/sales).
BOIRON: ACTIVITY IN 2020
in thousands of euros
in thousands of euros
Change in revenue
In the fourth quarter of 2020, the group s revenues were down 8.9%. This decrease mainly relates to specialities for winter illnesses: due to the health crisis and restrictions imposed in most countries, the level of winter illnesses has significantly declined over the period.
Sales were up 5.5% in France, however, driven by:
new product launches, including an innovative range of probiotics, Osmobiotic Flora
®, and two homeopathic specialties, Bocéal
® and Cocyntal
the increase in sales of non-proprietary medicines in December.
In Russia and North America, the decrease in specialties sales was driven by sharp declines in the ruble (exchange rate impact: -12% on sales) and the dollar (exchange rate impact: -7% on sales) over the period.